Last reviewed · How we verify
Malignant otitis externa due to Pseudomonas aeruginosa
Approved treatments
- Cortone
- Decadron · Generic (originally Merck)
- Ciprofloxacine · Poitiers University Hospital
- Cortef · Generic (originally Merck/Upjohn)
- Noroxin
- Floxin
- Cipro · Bayer AG
- Cortisol · University of Zurich
- Ofloxacine · Assistance Publique - Hôpitaux de Paris
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Malignant otitis externa due to Pseudomonas aeruginosa patent landscape — cliff calendar, originator estates, attackable patents
- Malignant otitis externa due to Pseudomonas aeruginosa treatment landscape brief
- Malignant otitis externa due to Pseudomonas aeruginosa treatment updates RSS
Frequently asked questions about Malignant otitis externa due to Pseudomonas aeruginosa
What drugs treat Malignant otitis externa due to Pseudomonas aeruginosa?
Tracked treatments include Cortone, Decadron, Ciprofloxacine, Cortef, Noroxin, Floxin, Cipro, Cortisol.
What is the treatment for Malignant otitis externa due to Pseudomonas aeruginosa?
Standard treatment for Malignant otitis externa due to Pseudomonas aeruginosa includes Cortone, Decadron, Ciprofloxacine, Cortef, Noroxin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Malignant otitis externa due to Pseudomonas aeruginosa patent cliff · Malignant otitis externa due to Pseudomonas aeruginosa CI report
- Treatment: Cortone
- Treatment: Decadron · Generic (originally Merck)
- Treatment: Ciprofloxacine · Poitiers University Hospital
- Treatment: Cortef · Generic (originally Merck/Upjohn)
- Treatment: Noroxin
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing